William J. Aronson

Q: What Schools Are Affiliated With William J. Aronson

William J. Aronson is affiliated with the following schools: University of California, Los Angeles, Stanford University, Duke University

William J. Aronson's AcademicInfluence.com Rankings

William J. Aronson

Engineering

#7441

World Rank

#8815

Historical Rank

Biomedical Engineering

#751

World Rank

#763

Historical Rank

engineering Degrees

William J. Aronson

Philosophy

#9893

World Rank

#13515

Historical Rank

Logic

#6843

World Rank

#8397

Historical Rank

philosophy Degrees

Download Badge

Engineering
Philosophy

William J. Aronson's Degrees

Doctorate Medicine Harvard University

Why Is William J. Aronson Influential?

(Suggest an Edit or Addition)

(See a Problem?)

William J. Aronson's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Radical prostatectomy versus observation for localized prostate cancer. (2012) (1359)
Nitric Oxide as a Mediator of Relaxation of the Corpus Cavernosum in Response to Nonadrenergic, Noncholinergic Neurotransmission (1992) (638)
Intensive lifestyle changes may affect the progression of prostate cancer. (2005) (438)
Follow‐up of Prostatectomy versus Observation for Early Prostate Cancer (2017) (430)
Phase II Study of Pomegranate Juice for Men with Rising Prostate-Specific Antigen following Surgery or Radiation for Prostate Cancer (2006) (418)
Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. (1992) (409)
Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group. (2004) (398)
Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. (2007) (332)
The correlation between metabolic syndrome and prostatic diseases. (2012) (317)
Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland. (2007) (275)
Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Prostate-specific antigen. (2003) (264)
Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study. (2005) (254)
Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality. (2019) (236)
Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer (2018) (221)
Nitric oxide is a potent relaxant of human and rabbit corpus cavernosum. (1992) (185)
Impact of diet on prostate cancer: a review (2005) (172)
Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications. (2006) (166)
Effect of Altering Dietary ω-6/ω-3 Fatty Acid Ratios on Prostate Cancer Membrane Composition, Cyclooxygenase-2, and Prostaglandin E2 (2006) (153)
Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy (2006) (153)
Carbohydrate restriction, prostate cancer growth, and the insulin‐like growth factor axis (2008) (149)
Modulation of omega-3/omega-6 polyunsaturated ratios with dietary fish oils in men with prostate cancer. (2001) (148)
Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score. (2002) (144)
Tea polyphenols and theaflavins are present in prostate tissue of humans and mice after green and black tea consumption. (2006) (143)
Predictors of metastatic disease in men with biochemical failure following radical prostatectomy. (2004) (135)
Time trends in biochemical recurrence after radical prostatectomy: results of the SEARCH database. (2003) (134)
Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-κB-dependent mechanism (2008) (129)
Ellagitannin-rich pomegranate extract inhibits angiogenesis in prostate cancer in vitro and in vivo. (2008) (127)
Nutrition, dietary interventions and prostate cancer: the latest evidence (2015) (126)
Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection. (2006) (124)
Effect of diet and exercise on serum insulin, IGF-I, and IGFBP-1 levels and growth of LNCaP cells in vitro (United States) (2002) (123)
The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer. (2009) (121)
Nitric oxide and cGMP: mediators of pelvic nerve-stimulated erection in dogs. (1993) (121)
Statin medication use and the risk of biochemical recurrence after radical prostatectomy (2010) (120)
A low‐fat diet and/or strenuous exercise alters the IGF axis in vivo and reduces prostate tumor cell growth in vitro (2003) (119)
Insulin-like growth factor I (IGF-I) and IGF binding protein-1 modulate prostate cancer cell growth and apoptosis: possible mediators for the effects of diet and exercise on cancer cell survival. (2003) (116)
Multi-institutional validation of the CAPRA-S score to predict disease recurrence and mortality after radical prostatectomy. (2014) (113)
Phenolic Acid Concentrations in Plasma and Urine from Men Consuming Green or Black Tea and their Chemopreventive Properties for Colon Cancer (2012) (109)
Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10 (2006) (107)
Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. (2002) (106)
Serum Lipid Profile and Risk of Prostate Cancer Recurrence: Results from the SEARCH Database (2014) (106)
Prostate cancer: another aspect of the insulin‐resistance syndrome? (2002) (103)
Obesity is a significant risk factor for prostate cancer at the time of biopsy. (2008) (102)
Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database. (2003) (97)
Effect of altering dietary omega-6/omega-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2. (2006) (97)
Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins. (2004) (96)
Exercise alters the IGF axis in vivo and increases p53 protein in prostate tumor cells in vitro. (2004) (91)
Effect of isocaloric low-fat diet on human LAPC-4 prostate cancer xenografts in severe combined immunodeficient mice and the insulin-like growth factor axis. (2003) (91)
Green Tea Polyphenols and Metabolites in Prostatectomy Tissue: Implications for Cancer Prevention (2010) (91)
Decreased growth of human prostate LNCaP tumors in SCID mice fed a low-fat, soy protein diet with isoflavones. (1999) (90)
Effect of low-fat diet on development of prostate cancer and Akt phosphorylation in the Hi-Myc transgenic mouse model. (2008) (85)
Evidence of an inhibitory effect of diet and exercise on prostate cancer cell growth. (2001) (85)
Effects of diet and exercise on insulin, sex hormone-binding globulin, and prostate-specific antigen. (1998) (83)
Growth inhibitory effect of low fat diet on prostate cancer cells: results of a prospective, randomized dietary intervention trial in men with prostate cancer. (2010) (82)
Delayed radical prostatectomy for intermediate‐risk prostate cancer is associated with biochemical recurrence: Possible implications for active surveillance from the SEARCH database (2013) (82)
Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis. (2017) (81)
Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT). (1997) (80)
Obesity is associated with castration‐resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database (2012) (78)
Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration‐resistant prostate cancer, and mortality after radical prostatectomy (2014) (76)
Outcomes after radical prostatectomy among men who are candidates for active surveillance: results from the SEARCH database. (2008) (75)
Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center. (2000) (74)
Predicting Time From Metastasis to Overall Survival in Castration‐Resistant Prostate Cancer: Results From SEARCH (2017) (72)
Association between tumor-associated macrophage infiltration, high grade prostate cancer, and biochemical recurrence after radical prostatectomy. (2013) (72)
Changing nature of high risk patients undergoing radical prostatectomy. (2007) (71)
Phase II Prospective Randomized Trial of a Low-Fat Diet with Fish Oil Supplementation in Men Undergoing Radical Prostatectomy (2011) (67)
Randomized clinical trial of brewed green and black tea in men with prostate cancer prior to prostatectomy (2015) (67)
Obesity as a predictor of adverse outcome across black and white race (2009) (67)
Do younger men have better biochemical outcomes after radical prostatectomy? (2004) (66)
Examining the relationship between obesity and prostate cancer. (2004) (66)
Race, biochemical disease recurrence, and prostate–specific antigen doubling time after radical prostatectomy (2007) (64)
Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy--results from the SEARCH database. (2007) (62)
Small transrectal ultrasound volume predicts clinically significant Gleason score upgrading after radical prostatectomy: results from the SEARCH database. (2008) (62)
Should a positive surgical margin following radical prostatectomy be pathological stage T2 or T3? Results from the SEARCH database. (2003) (62)
A mechanism to explain how regular exercise might reduce the risk for clinical prostate cancer (2007) (61)
Prostate cancer severity among low income, uninsured men. (2008) (61)
Chemoprevention of prostate cancer with lycopene in the TRAMP model (2010) (60)
Comparison of percentage of total prostate needle biopsy tissue with cancer to percentage of cores with cancer for predicting PSA recurrence after radical prostatectomy: results from the SEARCH database. (2003) (59)
Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database (2013) (58)
Preoperative p27 status is an independent predictor of prostate specific antigen failure following radical prostatectomy. (2003) (57)
Obesity and oncological outcome after radical prostatectomy: impact of prostate‐specific antigen‐based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center Databases (2008) (56)
Delay of radical prostatectomy and risk of biochemical progression in men with low risk prostate cancer. (2006) (56)
Clinical characteristics in black and white men with prostate cancer in an equal access medical center. (2000) (55)
Preoperative model for predicting prostate specific antigen recurrence after radical prostatectomy using percent of biopsy tissue with cancer, biopsy Gleason grade and serum prostate specific antigen. (2004) (55)
Late parasitemia in asymptomatic acquired toxoplasmosis. (1969) (55)
The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy (2003) (55)
Risk stratification of men with Gleason score 7 to 10 tumors by primary and secondary Gleason score: results from the SEARCH database. (2007) (54)
Predictors of Time to Metastasis in Castration-resistant Prostate Cancer. (2016) (52)
Obesity and positive surgical margins by anatomic location after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database (2008) (51)
Effect of Dietary Omega‐3 Fatty Acids on Tumor‐Associated Macrophages and Prostate Cancer Progression (2016) (51)
Comparison of preoperative prostate specific antigen density and prostate specific antigen for predicting recurrence after radical prostatectomy: results from the search data base. (2003) (51)
Role of Testosterone, Estradiol, and Insulin in Diet- and Exercise-Induced Reductions in Serum-Stimulated Prostate Cancer Cell Growth In Vitro (2002) (50)
Pathological and Biochemical Outcomes among African-American and Caucasian Men with Low Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance Candidacy. (2016) (48)
Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database (2014) (48)
A randomized, double-blind, placebo-controlled study of the effects of pomegranate extract on rising PSA levels in men following primary therapy for prostate cancer (2015) (48)
MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer (2019) (47)
Nutrition and prostate cancer. (1999) (47)
PSA in the new millennium: a powerful predictor of prostate cancer prognosis and radical prostatectomy outcomes--results from the SEARCH database. (2008) (46)
Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy. (2004) (45)
Preoperative PSA velocity and doubling time do not predict adverse pathologic features or biochemical recurrence after radical prostatectomy. (2001) (45)
Glycemic control and prostate cancer progression: Results from the SEARCH database (2010) (44)
Effect of Isocaloric Low-Fat Diet on Prostate Cancer Xenograft Progression to Androgen Independence (2004) (44)
Diabetes and Outcomes After Radical Prostatectomy: Are Results Affected by Obesity and Race? Results from the Shared Equal-Access Regional Cancer Hospital Database (2010) (42)
Validation of a nomogram to predict disease progression following salvage radiotherapy after radical prostatectomy: results from the SEARCH database (2009) (42)
Thresholds for PSA doubling time in men with non‐metastatic castration‐resistant prostate cancer (2017) (42)
Risk factors for male osteoporosis. (2003) (42)
Predictors of prostate‐specific antigen progression among men with seminal vesicle invasion at the time of radical prostatectomy (2004) (41)
Natural history of persistently elevated prostate specific antigen after radical prostatectomy: results from the SEARCH database. (2009) (41)
Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score. (2002) (41)
Obesity and prostate cancer-specific mortality after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database (2016) (40)
Obesity and prostate cancer. (2005) (40)
A lifestyle intervention of weight loss via a low-carbohydrate diet plus walking to reduce metabolic disturbances caused by androgen deprivation therapy among prostate cancer patients: carbohydrate and prostate study 1 (CAPS1) randomized controlled trial (2019) (39)
Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate. (2020) (38)
Effect of race and socioeconomic status on surgical margins and biochemical outcomes in an equal‐access health care setting (2012) (38)
Race and risk of metastases and survival after radical prostatectomy: Results from the SEARCH database (2017) (36)
A natural history of weight change in men with prostate cancer on androgen‐deprivation therapy (ADT): results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database (2011) (35)
Obesity, prostate-specific antigen nadir, and biochemical recurrence after radical prostatectomy: biology or technique? Results from the SEARCH database. (2012) (35)
Do skeletal-related events predict overall survival in men with metastatic castration-resistant prostate cancer? (2016) (34)
An update of research evidence on nutrition and prostate cancer. (2017) (34)
Dietary intervention strategies to modulate prostate cancer risk and prognosis (2009) (34)
Biochemical outcome after radical prostatectomy among men with normal preoperative serum prostate‐specific antigen levels (2004) (34)
Risk stratification for biochemical recurrence in men with positive surgical margins or extracapsular disease after radical prostatectomy: results from the SEARCH database. (2008) (33)
Fish Oil Slows Prostate Cancer Xenograft Growth Relative to Other Dietary Fats and is Associated with Decreased Mitochondrial and Insulin Pathway Gene Expression (2013) (33)
Analyzing Serum-Stimulated Prostate Cancer Cell Lines After Low-Fat, High-Fiber Diet and Exercise Intervention (2011) (32)
Body mass index, prostate weight and transrectal ultrasound prostate volume accuracy. (2007) (32)
Is biopsy Gleason score independently associated with biochemical progression following radical prostatectomy after adjusting for pathological Gleason score? (2006) (31)
Association of cigarette smoking with interval to biochemical recurrence after radical prostatectomy: results from the SEARCH database. (2010) (31)
Optimal timing, cutoff, and method of calculation of preoperative prostate-specific antigen velocity to predict relapse after prostatectomy: a report from SEARCH. (2007) (30)
Effect of diet and exercise intervention on the growth of prostate epithelial cells (2008) (30)
Impact of nerve sparing on surgical margins and biochemical recurrence: results from the SEARCH database (2009) (29)
Feasibility of a low-fat/high-fiber diet intervention with soy supplementation in prostate cancer patients after prostatectomy (2008) (29)
Neutrophil, lymphocyte and platelet counts, and risk of prostate cancer outcomes in white and black men: results from the SEARCH database (2018) (29)
The association between prostate size and Gleason score upgrading depends on the number of biopsy cores obtained: results from the Shared Equal Access Regional Cancer Hospital Database (2008) (28)
Predicting bone scan positivity in non-metastatic castration-resistant prostate cancer (2015) (27)
Race and Time from Diagnosis to Radical Prostatectomy: Does Equal Access Mean Equal Timely Access to the Operating Room?—Results from the SEARCH Database (2009) (27)
The impact of pathologic staging on the long‐term oncologic outcomes of patients with clinically high‐risk prostate cancer (2014) (26)
Effect of a Low-Fat Fish Oil Diet on Proinflammatory Eicosanoids and Cell-Cycle Progression Score in Men Undergoing Radical Prostatectomy (2013) (26)
Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database. (2003) (26)
Polycythemia Rubra Vera and Pregnancy (1983) (26)
Definition and preoperative predictors of persistently elevated prostate‐specific antigen after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database (2010) (25)
What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group. (2008) (25)
Effects of Calorie Restriction and IGF-1 Receptor Blockade on the Progression of 22Rv1 Prostate Cancer Xenografts (2013) (24)
Do nomograms predict aggressive recurrence after radical prostatectomy more accurately than biochemical recurrence alone? (2009) (24)
Number of Unfavorable Intermediate‐Risk Factors Predicts Pathologic Upstaging and Prostate Cancer‐Specific Mortality Following Radical Prostatectomy: Results From the SEARCH Database (2017) (24)
Clinical utility of percent prostate needle biopsy tissue with cancer cutpoints to risk stratify patients before radical prostatectomy. (2002) (24)
Detectable prostate-specific antigen Nadir during androgen-deprivation therapy predicts adverse prostate cancer-specific outcomes: results from the SEARCH database. (2014) (24)
Impact of age, comorbidity, and PSA doubling time on long-term competing risks for mortality among men with non-metastatic castration-resistant prostate cancer (2018) (24)
Exposure to Agent Orange is a significant predictor of prostate‐specific antigen (PSA)‐based recurrence and a rapid PSA doubling time after radical prostatectomy (2009) (24)
Obesity, race, and long‐term prostate cancer outcomes (2020) (23)
Predictors of secondary treatment following biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database (2010) (23)
Factors predicting skeletal‐related events in patients with bone metastatic castration‐resistant prostate cancer (2017) (22)
Positive surgical margins in radical prostatectomy patients do not predict long‐term oncological outcomes: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) cohort (2016) (22)
Long-term oncological outcomes of apical positive surgical margins at radical prostatectomy in the Shared Equal Access Regional Cancer Hospital cohort (2016) (21)
Multivariate analysis of race and adverse pathologic findings after radical prostatectomy. (2000) (21)
Do racial differences in prostate size explain higher serum prostate-specific antigen concentrations among black men? (2007) (21)
Preoperative weight change and risk of adverse outcome following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database (2011) (20)
Freedom from a detectable ultrasensitive prostate-specific antigen at two years after radical prostatectomy predicts a favorable clinical outcome: analysis of the SEARCH database. (2010) (20)
Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease (2019) (19)
Is a positive bladder neck margin truly a T4 lesion in the prostate specific antigen era? Results from the SEARCH Database. (2008) (19)
Effect of a Low-Fat Diet Combined with IGF-1 Receptor Blockade on 22Rv1 Prostate Cancer Xenografts (2012) (19)
Body mass index and prostate specific antigen as predictors of adverse pathology and biochemical recurrence after prostatectomy. (2009) (19)
Effect of Dietary Omega-3 Fatty Acids on Castrate Resistant Prostate Cancer and Tumor Associated Macrophages (2019) (19)
Validation of the 2015 prostate cancer grade groups for predicting long‐term oncologic outcomes in a shared equal‐access health system (2017) (18)
Is clinical stage T2c prostate cancer an intermediate‐ or high‐risk disease? (2015) (18)
Phase II Prospective Randomized Trial of Weight Loss Prior to Radical Prostatectomy (PCAN-17-0128) (2017) (18)
Do nomograms designed to predict biochemical recurrence (BCR) do a better job of predicting more clinically relevant prostate cancer outcomes than BCR? A report from the SEARCH database group. (2013) (18)
Does PSADT after radical prostatectomy correlate with overall survival?--a report from the SEARCH database group. (2011) (18)
Predicting biochemical recurrence after radical prostatectomy for patients with organ-confined disease using p27 expression. (2003) (18)
Poorly controlled diabetes increases the risk of metastases and castration‐resistant prostate cancer in men undergoing radical prostatectomy: Results from the SEARCH database (2019) (18)
Preclinical models relevant to diet, exercise, and cancer risk. (2005) (17)
Timing of Prostate-specific Antigen Nadir After Radical Prostatectomy and Risk of Biochemical Recurrence. (2017) (17)
Limitations of prostate specific antigen doubling time following biochemical recurrence after radical prostatectomy: results from the SEARCH database. (2008) (17)
Role of Host GPR120 in Mediating Dietary Omega-3 Fatty Acid Inhibition of Prostate Cancer (2018) (17)
Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis. (2020) (17)
Do all men with pathological Gleason score 8–10 prostate cancer have poor outcomes? Results from the SEARCH database (2016) (16)
Building a medical neighborhood in the safety net: an innovative technology improves hematuria workups. (2013) (16)
Socioeconomic status, race, and long-term outcomes after radical prostatectomy in an equal access health system: Results from the SEARCH database. (2019) (16)
Preoperative predictors of blood loss at the time of radical prostatectomy: results from the SEARCH database (2009) (16)
Benign Prostatic Hyperplasia: Does Lifestyle Play a Role? (2009) (16)
The effect of race/ethnicity on the accuracy of the 2001 Partin Tables for predicting pathologic stage of localized prostate cancer. (2008) (15)
PI-LBA06 VA CSP#553 CHEMOTHERAPY AFTER PROSTATECTOMY (CAP) FOR HIGH RISK PROSTATE CARCINOMA: A PHASE III RANDOMIZED STUDY (2016) (14)
Obesity, risk of biochemical recurrence, and prostate‐specific antigen doubling time after radical prostatectomy: results from the SEARCH database (2018) (14)
Prostate‐specific antigen level, stage or Gleason score: Which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database (2015) (14)
Predictors of operative time during radical retropubic prostatectomy and robot‐assisted laparoscopic prostatectomy (2017) (14)
Global Igfbp1 deletion does not affect prostate cancer development in a c-Myc transgenic mouse model. (2011) (14)
Does early prostate‐specific antigen doubling time (ePSADT) after radical prostatectomy, calculated using PSA values from the first detectable until the first recurrence value, correlate with standard PSADT? A report from the Shared Equal Access Regional Cancer Hospital Database Group (2009) (14)
Racial Differences in the Association Between Preoperative Serum Cholesterol and Prostate Cancer Recurrence: Results from the SEARCH Database (2016) (14)
Are repeat prostate biopsies safe? A cohort analysis from the SEARCH database. (2012) (14)
Predicting bone scan positivity after biochemical recurrence following radical prostatectomy in both hormone-naive men and patients receiving androgen-deprivation therapy: results from the SEARCH database (2014) (14)
Segmental testicular infarction in the neonate: a case report. (1995) (14)
Exclusion of the uniform tetraploid cells significantly improves specificity of the urine fish assay (2013) (13)
Diabetes predicts metastasis after radical prostatectomy in obese men: results from the SEARCH database (2013) (13)
The Influence of Hepatic Function on Prostate Cancer Outcomes Following Radical Prostatectomy (2010) (13)
Impact of prior local therapy on overall survival in men with metastatic castration‐resistant prostate cancer: Results from Shared Equal Access Regional Cancer Hospital (2018) (13)
Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study. (2017) (13)
Biopsy Detected Gleason Pattern 5 is Associated with Recurrence, Metastasis and Mortality in a Cohort of Men with High Risk Prostate Cancer (2017) (13)
The effect of race on the discriminatory accuracy of models to predict biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases (2010) (13)
Variations in payment patterns for surgical care in the centers for Medicare and Medicaid Services (2017) (12)
Keratin 13 Is Enriched in Prostate Tubule-Initiating Cells and May Identify Primary Prostate Tumors that Metastasize to the Bone (2016) (12)
Validity of the National Death Index to Ascertain the Date and Cause of Death in Men Having Undergone Prostatectomy for Prostate Cancer (2019) (12)
Postoperative prostate‐specific antigen nadir improves accuracy for predicting biochemical recurrence after radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) and Duke Prostate Center databases (2010) (12)
Predictors of skeletal‐related events and mortality in men with metastatic, castration‐resistant prostate cancer: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database (2019) (12)
Estimated blood loss as a predictor of PSA recurrence after radical prostatectomy: results from the SEARCH database (2010) (11)
Prospective randomized trial evaluating blood and prostate tissue concentrations of green tea polyphenols and quercetin in men with prostate cancer. (2020) (11)
Obese patients with castration‐resistant prostate cancer may be at a lower risk of all‐cause mortality: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database (2018) (11)
First postoperative PSA is associated with outcomes in patients with node positive prostate cancer: Results from the SEARCH database. (2018) (11)
Radical prostatectomy and the effect of close surgical margins: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database (2018) (10)
PD43-02 ARE WE OPERATING ON WHO WE SHOULD? THE CHANGING CHARACTERISTICS OF RADICAL PROSTATECTOMY PATIENTS: RESULTS FROM THE SHARED EQUAL ACCESS REGIONAL CANCER HOSPITAL (SEARCH) DATABASE (2016) (10)
In Men with Castration-Resistant Prostate Cancer, Visceral Metastases Predict Shorter Overall Survival: What Predicts Visceral Metastases? Results from the SEARCH Database. (2016) (10)
Is Ki67 prognostic for aggressive prostate cancer? A multicenter real-world study. (2018) (10)
Commentary on "Biallelic inactivation of BRCA2 in platinum-sensitive metastatic castration-resistant prostate cancer". Cheng HH, Pritchard CC, Boyd T, Nelson PS, Montgomery B. Eur Urol. Jun 2016;69(6):992-5. (2017) (10)
Smoking is a predictor of adverse pathological features at radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital database (2015) (10)
Practice patterns and predictors of followup imaging after a negative bone scan in men with castration resistant prostate cancer: results from the SEARCH database. (2015) (10)
Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH database. (2007) (10)
Re‐calibration and external validation of an existing nomogram to predict aggressive recurrences after radical prostatectomy (2009) (9)
Veterans Affairs Cooperative Studies Program Study #553: Chemotherapy After Prostatectomy for High-risk Prostate Carcinoma: A Phase III Randomized Study. (2020) (9)
Race does not predict the development of metastases in men with nonmetastatic castration‐resistant prostate cancer (2016) (9)
Cautery-Wire/Balloon Catheter for Fluoroscopically Guided Incision of Ureteral Strictures: A Phase I Study in Pigs (1991) (9)
Adverse pathology and undetectable ultrasensitive prostate‐specific antigen after radical prostatectomy: is adjuvant radiation warranted? (2016) (9)
Validation of a bone scan positivity risk table in non‐metastatic castration‐resistant prostate cancer (2016) (9)
Racial Discrepancies in Overall Survival among Men Treated with Radium-223. (2019) (9)
Competing Risks of Mortality Among Men with Biochemical Recurrence after Radical Prostatectomy. (2020) (8)
Does Early Prostate Specific Antigen Doubling Time after Radical Prostatectomy, Calculated Prior to Prostate Specific Antigen Recurrence, Correlate with Prostate Cancer Outcomes? A Report from the SEARCH Database Group (2017) (7)
Modified risk stratification grouping using standard clinical and biopsy information for patients undergoing radical prostatectomy: Results from SEARCH (2017) (7)
1418: Can Hemodilution Explain the Lower PSA Concentrations Among Obese Men? (2007) (7)
Is there a difference in outcome after radical prostatectomy between patients with biopsy Gleason sums 4, 5, and 6? results from the SEARCH database (2003) (7)
EDITORIAL: CAN WE LOWER THE MORTALITY RATE OF BLACK MEN WITH PROSTATE CANCER? (2000) (7)
Statins are Associated With Increased Biochemical Recurrence After Radical Prostatectomy in Diabetic Men but no Association was Seen in Men also Taking Metformin: Results From the SEARCH Database (2019) (6)
Characterization of a “low‐risk” cohort of grade group 2 prostate cancer patients: Results from the Shared Equal Access Regional Cancer Hospital database (2017) (6)
Invited commentary: Lower urinary tract symptoms and inflammation--weighing the evidence. (2009) (6)
Is computed tomography a necessary part of a metastatic evaluation for castration‐resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital Database (2016) (6)
Time Trends in Use of Radical Prostatectomy by Tumor Risk and Life Expectancy in a National Veterans Affairs Cohort (2021) (6)
The L-arginine-nitric oxide-cyclic GMP pathway mediates inhibitory nonadrenergic-noncholinergic neurotransmission in the corpus cavernosum of human and rabbit (1993) (6)
Diabetes and Prostate Cancer Outcomes in Obese and Nonobese Men After Radical Prostatectomy (2021) (5)
Fish oil slows prostate cancer xenograft growth relative to other dietary fats and is associated with decreased mitochondrial and insulin pathway gene expression (2013) (5)
AJCC Cancer Staging Atlas (2007) (5)
Nutritional approaches to the prevention of prostate cancer progression. (1996) (5)
Red Blood Cell Distribution Width Is Associated with All-cause Mortality but Not Adverse Cancer-specific Outcomes in Men with Clinically Localized Prostate Cancer Treated with Radical Prostatectomy: Findings Based on a Multicenter Shared Equal Access Regional Cancer Hospital Registry (2022) (5)
Agent Orange and long-term outcomes after radical prostatectomy. (2015) (5)
Association between Delay to Radical Prostatectomy and Clinically Meaningful Outcomes among Patients with Intermediate and High-Risk Localized Prostate Cancer (2021) (5)
437: Obesity is an Independent Predictor of Biochemical Failure Following Radical Prostatectomy (2004) (4)
1281 Associations Between C-Reactive Protein and Benign Prostatic Hyperplasia/Lower Urinary Tract Symptom Outcomes in a Population-based Cohort. Jennifer L. St. Sauver, (2009) (4)
LONG TERM FOLLOW UP OF PHASE 2 STUDY OF POMEGRANATE JUICE FOR MEN WITH PROSTATE CANCER SHOWS DURABLE PROLONGATION OF PSA DOUBLING TIME (2009) (4)
Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: Results from the SEARCH database (2014) (4)
High serum folate is associated with reduced biochemical recurrence after radical prostatectomy: results from the SEARCH Database. (2013) (4)
Serum Lipids Prior to Starting Androgen Deprivation Therapy and Risk of Castration-Resistant Prostate Cancer and Metastasis: Results from the SEARCH Database. (2020) (4)
Re: Weight Loss with a Low-Carbohydrate, Mediterranean, or Low-Fat Diet (2009) (4)
Erratum: Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate cancer, and mortality after radical prostatectomy (Cancer (2014), 120 (197-204)) (2015) (4)
Safety of concomitant therapy with radium‐223 and abiraterone or enzalutamide in a real‐world population (2021) (4)
1162: Can Unilateral Prostate Cancer Be Reliably Predicted Based Upon Biopsy Features? (2006) (4)
Impact of Diet on Prostate Cancer (2005) (4)
First-year weight loss with androgen-deprivation therapy increases risks of prostate cancer progression and prostate cancer-specific mortality: results from SEARCH (2019) (3)
Practice patterns and outcomes of equivocal bone scans for patients with castration-resistant prostate cancer: Results from SEARCH (2019) (3)
The Impact of 18F-DCFPyL PET-CT Imaging on Initial Staging, Radiation, and Systemic Therapy Treatment Recommendations for Veterans With Aggressive Prostate Cancer (2020) (3)
Does race predict the development of metastases in men who receive androgen‐deprivation therapy for a biochemical recurrence after radical prostatectomy? (2018) (3)
Obese men undergoing radical prostatectomy: Is robotic or retropubic better to limit positive surgical margins? Results from SEARCH (2020) (3)
MP04-06 A PROSPECTIVE RANDOMIZED TRIAL OF DIETARY CARBOHYDRATE RESTRICTION FOR MEN INITIATING ANDROGEN DEPRIVATION THERAPY: CARBOHYDRATE AND PROSTATE STUDY I (CAPS1) (2016) (3)
MP87-09 WHEN IS AN EQUIVOCAL BONE SCAN NOT REALLY EQUIVOCAL? RESULTS FROM SEARCH (2015) (3)
Influence of African American race on the association between preoperative biopsy grade group and adverse histopathologic features of radical prostatectomy (2019) (3)
Effects of dietary omega-3 fatty acids on orthotopic prostate cancer progression, tumor associated macrophages, angiogenesis and T-cell activation—dependence on GPR120 (2022) (3)
241 DO NOMOGRAMS DESIGNED TO PREDICT BIOCHEMICAL RECURRENCE (BCR) DO A BETTER JOB OF PREDICTING MORE DISTANT PROSTATE CANCER OUTCOMES THAN BCR?–A REPORT FROM THE SEARCH DATABASE GROUP (2010) (3)
Radiotherapy versus radical prostatectomy for Gleason score 9-10 prostate adenocarcinoma: A multi-institutional comparative analysis of 1001 patients treated in the modern era. (2017) (3)
860 DOES BEING ON ADT ALTER THE ABILITY OF PSA AND PSADT TO PREDICT A POSITIVE BONE SCAN? RESULTS FROM THE SEARCH DATABASE (2010) (2)
RISK STRATIFICATION AMONG MEN WITH POSITIVE SURGICAL MARGINS OR EXTRACAPSULAR DISEASE AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SHARED EQUAL ACCESS REGIONAL CANCER HOSPITAL (SEARCH) DATABASE (2008) (2)
Prostate weight and prostate cancer outcomes after radical prostatectomy: Results from the SEARCH cohort study (2021) (2)
Carcinoma of the penis and scrotum (1994) (2)
OBESITY AS A PREDICTOR OF ADVERSE OUTCOME ACROSS BLACK AND WHITE RACE: RESULTS FROM THE SEARCH AND DUKE PROSTATE CENTER DATABASES (2008) (2)
1508: Obesity, Serum PSA, and Prostate Size: Implications for Prostate Cancer Detection (2006) (2)
Fluoroscopically guided incision of ureteral strictures in pigs with the cautery-wire balloon catheter: a phase 1 study. (1993) (2)
Is Clinical Stage T 2 C Prostate Cancer Intermediate or High-Risk Disease ? (2015) (2)
Monocyte counts and prostate cancer outcomes in white and black men: results from the SEARCH database (2021) (1)
Combination of Quercetin and Green Tea Extract Increased Plasma Epicatechingallate and Decreased Urine Epigallocatechin and Epicatechin Concentrations (2017) (1)
Can we lower the mortality rate of black men with prostate cancer? (2000) (1)
Do Hispanic men have worse outcomes after radical prostatectomy? Results from SEARCH: Hispanic men outcomes: Results from SEARCH. (2020) (1)
Does salvage radiation therapy change the biology of recurrent prostate cancer based on PSA doubling times? Results from the SEARCH database. (2012) (1)
STATIN MEDICATION USE AND THE RISK OF BIOCHEMICAL RECURRENCE FOLLOWING RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2009) (1)
289 ASSOCIATION OF CIGARETTE SMOKING WITH TIME TO BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2010) (1)
IS PSA A POOR PREDICTOR OF PROSTATE CANCER IN OBESE MEN (2008) (1)
131: Agent Orange Exposure and Risk of Advanced Disease and Biochemical Progression after Radical Prostatectomy: Results from the Search Database (2006) (1)
1030: Do Younger Men have Better Biochemical Outcomes Following Radical Prostatectomy? (2004) (1)
BODY MASS INDEX AND PROSTATE-SPECIFIC ANTIGEN AS A PREDICTOR OF ADVERSE PATHOLOGY AND BIOCHEMICAL RECURRENCE FOLLOWING RADICAL PROSTATECTOMY (2009) (1)
RECALIBRATION AND EXTERNAL VALIDATION OF AN EXISTING NOMOGRAM TO PREDICT AGGRESSIVE RECURRENCES AFTER RADICAL PROSTATECTOMY (RP) (2009) (1)
Effects of brewed green and black tea on inflammation, apoptosis and oxidation in men with prostate cancer (136.3) (2014) (1)
249: Inhibitory Effect of Dietary Fish Oil (Omega-3 Fatty Acids) on Human Prostate Cancer Progression in Severe-Combined Immunodeficient Mice (2005) (1)
IS PSA A POOR PREDICTOR OF ADVERSE PATHOLOGY AND BIOCHEMICAL FAILURE FOLLOWING RADICAL PROSTATECTOMY IN OBESE MEN (2008) (1)
Racial Differences in Prognostic Value of Adult Height for Biochemical Progression Following Radical Prostatectomy (2005) (1)
97 DOES TYPE OF DIETARY FAT MATTER? PROSTATE CANCER XENOGRAFT PROGRESSION IN A SCID MOUSE MODEL WITH VARYING DIETARY FAT SOURCES (2010) (1)
Racial disparities in radium-223 treatment in a large real-world population. (2019) (1)
MP53-01 THE RELATIONSHIP OF OBESITY, PATHOLOGIC GLEASON GRADE AND PROSTATE CANCER TUMOR VOLUME AT THE TIME OF RADICAL PROSTATECTOMY—RESULTS FROM THE SEARCH DATABASE (2015) (1)
Abstract B67: Inhibition of NFκB and proapoptotic Effect of Green Tea in Prostate Tumor Tissue: A Phase II clinical Trial in Men with Prostate Cancer (2012) (1)
2292 PSA NADIR DURING ANDROGEN DEPRIVATION THERAPY PREDICTS ADVERSE PROSTATE CANCER SPECIFIC OUTCOMES: RESULTS FROM THE SEARCH DATABASE (2011) (1)
Utilization and impact of surgical technique on the performance of pelvic lymph node dissection at radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital database (2016) (1)
Dietary Omega-6 and Omega-3 Fatty Acids and Prostate Cancer – Response (2012) (1)
DIABETES AND OUTCOMES AFTER RADICAL PROSTATECTOMY - ARE RESULTS AFFECTED BY OBESITY AND RACE? RESULTS FROM THE SHARED EQUAL ACCESS REGIONAL CANCER HOSPITAL (SEARCH) DATABASE (2009) (1)
The Impact of Comorbidity and Age on Timing of Androgen Deprivation Therapy in Men with Biochemical Recurrence after Radical Prostatectomy. (2018) (1)
2294 OBESE MEN ARE MORE LIKELY TO HAVE HIGHER PSA NADIR VALUES AFTER RADICAL PROSTATECTOMY (RP), THOUGH THIS DOES NOT EXPLAIN THE HIGHER BIOCHEMICAL RECURRENCE (BCR) RATES: RESULTS FROM THE SEARCH DATABASE (2011) (1)
AJCC Cancer Staging Atlas, F.L. Greene, C.C. Compton, D.P. Winchester, A.G. Fritz, J. Shah. Springer, New York (2006), 352 pages (2007) (1)
PD14-10 VALIDITY OF THE NATIONAL DEATH INDEX TO ACCURATELY CODE THE DATE OF DEATH AND DEATHS FROM PROSTATE CANCER, IN MEN HAVING UNDERGONE PROSTATECTOMY (2018) (1)
Can Gleason 7 prostate cancer ever be low-risk? Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. (2015) (1)
Salvage Radiotherapy for Recurrent Prostate Cancer: Can the Prognostic Grade Group System Inform Treatment Timing? (2019) (1)
WHAT ARE THE FACTORS ASSOCIATED WITH A SHORT PSA DOUBLING TIME? A REPORT FROM THE SEARCH DATABASE GROUP (2008) (1)
Do Racial Differences In Prostate Size Explain Higher Serum PSA Concentrations Among Black Men? (2012) (1)
RADICAL PROSTATECTOMY VERSUS OBSERVATION FOR EARLY PROSTATE CANCER: FOLLOW‐UP RESULTS OF THE PROSTATE CANCER INTERVENTION VERSUS OBSERVATION TRIAL (PIVOT): PNFLBA‐11 (2017) (1)
MP78-03 PREDICTORS OF TIME TO METASTASIS IN NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (2014) (1)
PD38-11 ADVERSE PATHOLOGY YET UNDETECTABLE ULTRASENSITIVE PSA: IS ADJUVANT RADIATION REALLY NECESSARY? (2015) (1)
DOES EARLY PSADT (EPSADT) AFTER RADICAL PROSTATECTOMY, CALCULATED PRIOR TO PSA RECURRENCE, CORRELATE WITH PROSTATE CANCER (PC) OUTCOMES? RESULTS FROM THE SEARCH DATABASE: PD40‐07 (2017) (1)
Race does not predict skeletal‐related events and all‐cause mortality in men with castration‐resistant prostate cancer (2020) (1)
Effect of the ERα agonist, GTx-758 (250 mg daily), on total and free testosterone, and PSA, in men with castration resistant prostate cancer (CRPC) maintained on LHRH therapy. (2015) (1)
MP34-11 OBESITY, RISK OF BIOCHEMICAL RECURRENCE, AND PSADT AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2018) (1)
64 THE EFFECT OF RACE AND SOCIOECONOMIC STATUS ON SURGICAL MARGINS AND BIOCHEMICAL OUTCOMES IN AN EQUAL-ACCESS HEALTHCARE SETTING: RESULTS FROM THE SEARCH DATABASE (2012) (1)
Utilization and impact of surgical technique on the performance of pelvic lymph node dissection at radical prostatectomy: Results from the SEARCH database. (2015) (1)
Abstract B68: Antioxidant activity of green tea: A phase II clinical trial in men with prostate cancer (2012) (1)
Chapter 38 – COMPLICATIONS OF URETERAL SURGERY (2010) (1)
Phase 2 Trial of GTx-758, an Estrogen Receptor Alpha Agonist, in Men With Castration-Resistant Prostate Cancer. (2020) (1)
Radium-223 treatment patterns in a large real-world population. (2019) (0)
IN MEN WITH CASTRATION‐RESISTANT PROSTATE CANCER VISCERAL METASTASES PREDICTS SHORTER OVERALL SURVIVAL: WHAT PREDICTS VISCERAL METASTASES? RESULTS FROM THE SEARCH DATABASE: PD24‐09 (2017) (0)
MP87-08 IS COMPUTERIZED TOMOGRAPHY A NECESSARY PART OF A PROSTATE CANCER METASTATIC WORKUP? RESULTS FROM SEARCH (2015) (0)
683P Correlation between castration resistant prostate cancer (CRPC) free survival (CRPC-FS) and metastasis free survival (MFS) in men initiating androgen deprivation therapy (ADT) for biochemical recurrence (BCR) after radical prostatectomy (RP): Results from the SEARCH database (2020) (0)
Does salvage radiation therapy (SRT) change the biology of recurrent prostate cancer (PCa) based on PSA doubling times (PSADT)? Results from the SEARCH database. (2012) (0)
393: African American Race, Risk of Biochemical Recurrence, and Psadt after Radical Prostatectomy (2007) (0)
PD32-03 A PHASE 2 OPEN-LABEL TRIAL OF GTX-758 IN MEN WITH CASTRATION-RESISTANT PROSTATE CANCER, FINAL ANALYSIS OF THE PRIMARY ENDPOINT (2016) (0)
A 60-year-old man with gross hematuria and flank pain. (2014) (0)
Is clinical stage T2c prostate cancer intermediate- or high-risk disease? Results from the SEARCH database. (2014) (0)
NITRICOXIDE AS A MEDIATOR OF RELAXATION OF THE CORPUS CAVERNOSUM. AUTHOR'SREPLIES (1992) (0)
CLINICAL CHARACTERISTICS AND SURGICAL OUTCOME IN BLACK AND WHITE MEN WITH PROSTATE CANCER IN AN EQUAL ACCESS MEDICAL CENTER (1999) (0)
ANALYSIS OF THE PREDICTIVE UTILITY OF PROGNOSTIC GRADE GROUPS (PGG) FOR PREDICTING PERIOPERATIVE ONCOLOGIC OUTCOMES OF RADICAL PROSTATECTOMY IN THE SHARED EQUAL ACCESS REGIONAL CANCER HOSPITAL (SEARCH) DATABASE: PD10‐11 (2017) (0)
719 SALVAGE RADIATION THERAPY AFTER RECURRENT PROSTATE CANCER: HOW EARLY DO WE NEED TO BE ? (2013) (0)
328: Are the Partin Tables Accurate for African-American men in the United States? (2007) (0)
Prospective study on the value of PSMA-based 18F-DCFPyL PET/CT scanning in the evaluation of patients with prostate cancer: how does it change the clinical management? (2021) (0)
846: Is a Positive Bladder Neck Margin Truly a T4 Lesion in the PSA ERA? Results from the Search Database (2007) (0)
644 OBESITY IS ASSOCIATED WITH CASTRATE RESISTANT DISEASE AND METASTASIS IN MEN TREATED WITH ANDROGEN DEPRIVATION THERAPY (ADT) FOR PSA-ONLY RECURRENCE AFTER RADICAL PROSTATECTOMY (RP): RESULTS FROM THE SEARCH DATABASE (2011) (0)
736 PRO-INFLAMMATORY AND MITOGENIC ACTIVITY OF PERIPROSTATIC ADIPOSE TISSUE IN PROSTATE CANCER (2011) (0)
Is time to castration resistant prostate cancer a potential intermediate end-point for time to metastasis among men initiating androgen deprivation therapy for non-metastatic prostate cancer with rapid PSA doubling time (<9 months)? (2022) (0)
DYNAMIC SCREENING DETECTS PROSTATE CANCER (PC) EARLIER AND WOULD LEAD TO IMRPROVED CANCER CONTROL: RESULTS FROM THE DUKE PROSTATE CENTER AND THE SEARCH DATABASE (2008) (0)
902 PREDICTORS OF PROSTATE CANCER-SPECIFIC MORTALITY IN PATIENTS WITH RESIDUAL DISEASE AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2011) (0)
MP53-12 LONG TERM ONCOLOGICAL OUTCOMES OF APICAL POSITIVE SURGICAL MARGINS AT RADICAL PROSTATECTOMY IN THE SHARED EQUAL ACCESS REGIONAL CANCER HOSPITAL (SEARCH) COHORT (2015) (0)
Abstract B72: Metformin use and risk of biochemical recurrence following radical prostatectomy: Results from the SEARCH database (2012) (0)
Seminar article Risk factors for male osteoporosis (2003) (0)
Reply to the letter by Demark-Wahnefried et al. (2018) (0)
DOES EARLY PSADT, CALCULATED STARTING AT THE FIRST DETECTABLE PSA AFTER RADICAL PROSTATECTOMY (RP), CORRELATE WITH STANDARD PSADT? A REPORT FROM THE SEARCH DATABASE GROUP (2008) (0)
Evaluation of the ER{alpha} agonist, GTx-758 (250 mg daily), in men with metastatic (mCRPC) and nonmetastatic castration-resistant prostate cancer (nmCRPC). (2015) (0)
MP82-15 DOES EARLY ANDROGEN DEPRIVATION THERAPY AFTER BIOCHEMICAL RECURRENCE FOLLOWING RADICAL PROSTATECTOMY INCREASE OVERALL SURVIVAL? RESULTS FROM SEARCH (2015) (0)
PD28-05 FACTORS PREDICTING SKELETAL-RELATED EVENTS IN PATIENTS WITH BONE METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (2016) (0)
MP57-03 IS ADVERSE PATHOLOGY AT THE TIME OF RADICAL PROSTATECTOMY A USEFUL PREDICTOR OF LONG-TERM OUTCOMES IN ACTIVE SURVEILLANCE CANDIDATES? RESULTS FROM THE SEARCH COHORT (2022) (0)
Title Utilization and impact of surgical technique on the performance of pelvic lymph node dissection at radical prostatectomy : Results from the SEARCH database (2016) (0)
MP21-03 SERUM LIPID PROFILE AT TIME OF ANDROGEN DEPRIVATION THERAPY AND RISK OF CASTRATION-RESISTANT PROSTATE CANCER: RESULTS FROM THE SEARCH DATABASE (2018) (0)
OVER THE LAST 15+ YEARS, THE PERCENTAGE OF MEN UNDERGOING RADICAL PROSTATECTOMY WHO ARE CANDIDATES FOR ACTIVE SURVEILLANCE HAS NOT CHANGED: RESULTS FROM THE SEARCH DATABASE (2008) (0)
Reply by Authors. (2019) (0)
PD14-12 SECONDARY OUTCOMES OF A PROSPECTIVE RANDOMIZED TRIAL OF DIETARY CARBOHYDRATE RESTRICTION FOR MEN INITIATING ANDROGEN DEPRIVATION THERAPY: CARBOHYDRATE AND PROSTATE STUDY I (CAPS1) (2018) (0)
667: Pathological and Biochemical Outcomes after Radical Prostatectomy for Men with a Biopsy Gleason Score of 8 to 10 (2006) (0)
1464 EXTRACAPSULAR EXTENSION PREDICTS LATE RECURRENCE IN PATIENTS WHO ACHIEVE UNDETECTABLE PSA AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2011) (0)
Risk Stratification of Men with Gleason 7–10 tumors by Primary and Secondary Gleason Score: Results from the SEARCH Database (2012) (0)
PD16-10 RACE DOES NOT PREDICT SKELETAL RELATED EVENTS AND ALL-CAUSE MORTALITY IN MEN WITH CASTRATE RESISTANT PROSTATE CANCER (2020) (0)
MP6-08 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE EFFECTS OF POMEGRANATE EXTRACT ON RISING PROSTATE SPECIFIC ANTIGEN (PSA) LEVELS IN MEN FOLLOWING PRIMARY THERAPY FOR PROSTATE CANCER (2015) (0)
DO NOMOGRAMS PREDICT AGGRESSIVE RECURRENCE AFTER RADICAL PROSTATECTOMY MORE ACCURATELY THAN BIOCHEMICAL RECURRENCE ALONE (2009) (0)
Abstract 880: Obesity predicts prostate cancer-specific mortality after radical prostatectomy: Results from the SEARCH database (2015) (0)
Exercise for Prevention and Treatment of Prostate Cancer: Cellular Mechanisms (2010) (0)
2284 : Preoperative PSA Velocity Predicts for Relapse After Prostatectomy Only for Non-Obese (Low BMI) Patients (2006) (0)
PD34-07 CAN GLEASON 7 PROSTATE CANCER EVER BE LOW-RISK? RESULTS FROM THE SHARED EQUAL ACCESS REGIONAL CANCER HOSPITAL (SEARCH) DATABASE (2015) (0)
MP32-15 COMPARISON OF THE PROSTATE CANCER COMORBIDITY INDEX AND AMERICAN ANESTHESIOLOGY ASSOCIATION SCORE IN PREDICTION OF MORTALITY IN MEN UNDERGOING RADICAL PROSTATECTOMY (2021) (0)
PREDICTORS OF CASTRATION RESISTANT PROSTATE CANCER IN MEN UNDERGOING SALVAGE ANDROGEN DEPRIVATION THERAPY - RESULTS FROM THE SEARCH DATABASE (2009) (0)
1648: Multi-Institutional Validation of the UCSF Cancer of the Rostate Risk Assessment (CAPRA) for Prediction of Recurrence Following Radical Prostatectomy (2006) (0)
600: Effect of Dietary Omega-6 Fatty Acid on Androgen-Independent Prostate Tumor Progression and Survival in Severe Combined Immunodeficiency Mice (2004) (0)
WHAT ARE THE BEST CUT‐POINTS FOR PSA DOUBLING TIME IN MEN WITH NON‐METASTATIC CASTRATION‐RESISTANT PROSTATE CANCER?: MP20‐19 (2017) (0)
1497 OVERSTAGING HIGH-RISK PROSTATE CANCER MAY LEAD TO OVERTREATMENT: RESULTS FROM THE SEARCH DATABASE (2013) (0)
Prostate Cancer: Localized (I)Podium Session 6357 RADICAL PROSTATECTOMY AND THE EFFECT OF CLOSE SURGICAL MARGINS: ANALYSIS FROM THE SEARCH DATABASE (2013) (0)
MP35-16 IS KI67 PROGNOSTIC FOR AGGRESSIVE PROSTATE CANCER? A MULTICENTER REAL-WORLD STUDY (2018) (0)
Abstract LB-458: Additive effects of caloric restriction and IGF-I receptor blockade on the progression of 22RV1 prostate cancer xenografts (2011) (0)
MP64-15 ASSOCIATION BETWEEN DELAY TO SURGERY AND CLINICALLY MEANINGFUL OUTCOMES AMONG PATIENTS WITH INTERMEDIATE- AND HIGH-RISK LOCALIZED PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY: AN ASSESSMENT OF THE SEARCH DATABASE WITH INSIGHT INTO THE ROLE OF NEOADJUVANT ANDROGEN DEPRIVATION THERAPY (2021) (0)
MP54-14 TIME TRENDS IN USE OF RADICAL PROSTATECTOMY BY TUMOR RISK AND LIFE EXPECTANCY IN A NATIONAL VA COHORT FROM 2000 TO 2017 (2019) (0)
997 RISK FOR RECURRENT PROSTATE CANCER INCREASES WITH CHOLESTEROL ON A CONTINUUM IN MEN WITH ABNORMAL CHOLESTEROL LEVELS - AN UPDATE FROM THE SEACH DATABASE (2011) (0)
PD62-08 PREDICTED RISK OF PROSTATE CANCER-SPECIFIC MORTALITY ON ACTIVE SURVEILLANCE FOR MEN WITH FAVORABLE INTERMEDIATE RISK PROSTATE CANCER (2020) (0)
A lifestyle intervention of weight loss via a low-carbohydrate diet plus walking to reduce metabolic disturbances caused by androgen deprivation therapy among prostate cancer patients: carbohydrate and prostate study 1 (CAPS1) randomized controlled trial (2019) (0)
The Impact of Blue Light Cystoscopy Use Among Non-Muscle Invasive Bladder Cancer Patients in an Equal Access Setting: Implications on Recurrence and Time to Recurrence (2023) (0)
MP09-18 BIOPSY-DETECTED GLEASON PATTERN 5 IS A PARTICULARLY STRONG PREOPERATIVE PREDICTOR OF RECURRENCE, METASTASIS, AND MORTALITY IN MEN WITH HIGH-RISK PROSTATE CANCER (2016) (0)
Moreira DM, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Boffetta P and Freedland SJ. Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration‐resistant prostate cancer, and mortality after radical prostatectomy. Cancer. 2014;120:1 (2015) (0)
338 DO REPEATED PROSTATE BIOPSIES WORSEN THE OUTCOME AMONG MEN WITH PROSTATE CANCER WHO HAVE A RADICAL PROSTATECTOMY? RESULTS FROM THE SEARCH DATABASE (2011) (0)
Oncology Does Salvage Radiation Therapy Change the Biology of Recurrent Prostate Cancer Based on PSA Doubling Times? Results from the SEARCH Database (2012) (0)
MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer (2019) (0)
First-year weight loss with androgen-deprivation therapy increases risks of prostate cancer progression and prostate cancer-specific mortality: results from SEARCH (2019) (0)
1610: High-Risk Patients Undergoing Radical Prostatectomy Today are Less High-Risk than in the Past (2005) (0)
Reply by Authors. (2022) (0)
Impact of age, comorbidity, and PSA doubling time on long-term competing risks for mortality among men with non-metastatic castration-resistant prostate cancer (2017) (0)
16: Nerve Sparing Does not Increase the Risk of Biochemical Recurrence: Results from the Search Database (2007) (0)
MP4-17 PATHOLOGIC GLEASON 8-10: DO ALL MEN DO POORLY? RESULTS FROM THE SEARCH DATABASE (2015) (0)
PSA VELOCITY (PSAV) TO CANCER-SPECIFIC PSA (PSA(PCA)) RATIO INCREASES WITH HIGHER GLEASON SCORE: RESULTS FROM THE SEARCH DATABASE (2008) (0)
964 CIGARETTE SMOKING IS ASSOCIATED WITH SHORTER TIME FROM RADICAL PROSTATECTOMY TO METASTASIS: RESULTS FROM THE SEARCH DATABASE (2013) (0)
A Case of an Invisible Ureteral Stent. (2018) (0)
Obese men, higher PSA nadir values after radical prostatectomy (RP), and higher biochemical recurrence (BCR) rates: Results from the SEARCH database. (2011) (0)
MP50-13 VALIDATION OF A BONE SCAN POSITIVITY RISK TABLE IN NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (2016) (0)
Nutrition and prostate cancer : Hormone refractory prostate cancer (1999) (0)
997 DELAYED RADICAL PROSTATECTOMY IN GLEASON 7 PROSTATE CANCER DECREASES TIME TO BIOCHEMICAL RECURRENCE: RESULTS FROM THE SEARCH DATABASE (2012) (0)
Reply by Authors. (2019) (0)
MP42-09 PREDICTING BONE SCAN POSITIVITY IN CASTRATION-RESISTANT PROSTATE CANCER (2014) (0)
739 PHASE II PROSPECTIVE RANDOMIZED TRIAL OF ALTERING THE DIETARY RATIO OF OMEGA-6 TO OMEGA-3 FATTY ACIDS IN MEN UNDERGOING RADICAL PROSTATECTOMY (2011) (0)
Session 3 Preclinical models with relevance to clinical cancer prevention (2004) (0)
Radium-223 Utilization Patterns and Outcomes in Clinical Practice. (2022) (0)
387: The Optimal Timing, Cutoff and Method of Calculation of Preoperative PSA Velocity to Predict Relapse after Prostatectomy: A Report from Search (2007) (0)
Clinical Outcomes for Patients With Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiation Therapy or Radical Prostatectomy: A Comparative Analysis (2016) (0)
NOVEL RISK STRATIFICATION GROUPING USING STANDARD CLINICAL AND BIOPSY INFORMATION FOR PATIENTS UNDERGOING RADICAL PROSTATECTOMY: RESULTS FROM SEARCH: MP20‐02 (2017) (0)
Impact of darolutamide on local symptoms: pre‐planned and post hoc analyses of the ARAMIS trial (2022) (0)
Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease (2019) (0)
Time from biopsy to radical prostatectomy by race in an equal-access healthcare system: Results from the SEARCH cohort. (2023) (0)
2060 DOES PSA DOUBLING TIME AFTER RADICAL PROSTATECTOMY CORRELATE WITH OVERALL SURVIVAL? A REPORT FROM THE SEARCH DATABASE GROUP (2010) (0)
292 DOES INITIATING STATIN THERAPY AFTER RADICAL PROSTATECTOMY REDUCE THE RISK FOR BIOCHEMICAL RECURRENCE? – RESULTS FROM THE SEARCH DATABASE (2010) (0)
1262: Men with Normal Pre-Operative Serum PSA Values have Better Biochemical Outcomes Following Radical Prostatectomy (2004) (0)
150 THE NATURAL HISTORY OF ULTRASENSITIVE PSA FOLLOWING RADICAL PROSTATECTOMY (2011) (0)
MP53-02 IS CLINICAL STAGE T2C PROSTATE CANCER INTERMEDIATE OR HIGH-RISK DISEASE? (2015) (0)
PREDICTORS OF SECONDARY TREATMENT FOLLOWING BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2009) (0)
PD13-04 LONG-TERM COMPETING RISKS OF MORTALITY AMONG MEN WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY (2020) (0)
Abstract LB-429: Synergistic effects of low-fat diet combined with IGF-I receptor blockade on 22RV1 prostate cancer xenografts (2010) (0)
81 EFFECT OF DIETARY OMEGA-6 FATTY ACID ON ANDROGEN-INDEPENDENT PROSTATE TUMOR PROGRESSION AND SURVIVAL IN SEVERE COMBINED IMMUNODEFICIENCY MICE. (2004) (0)
Validation of the prostate cancer comorbidity index in predicting cause-specific mortality in men undergoing radical prostatectomy. (2022) (0)
145: A No-Carbohydrate Diet Significantly Delays Prostate Cancer Growth in an Animal Model (2007) (0)
474: Significance of the Apical Margin in Radical Prostatectomy: Results from the Search Database (2007) (0)
Effect of dietary omega-3 fatty acids on castrate-resistant prostate cancer and tumor-associated macrophages (2019) (0)
442 EFFECT OF DIETARY OMEGA-6 FATTY ACID ON ANDROGEN-INDEPENDENT PROSTATE TUMOR PROGRESSION AND SURVIVAL IN SEVERE COMBINED IMMUNODEFICIENCY MICE. (2004) (0)
PD34-10 IMPACT OF DAROLUTAMIDE ON LOCAL SYMPTOMS IN PATIENTS WITH NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER (2021) (0)
MP60-12 DOES LARGER TUMOR VOLUME EXPLAIN THE HIGHER PROSTATE SPECIFIC ANTIGEN LEVELS IN BLACK MEN WITH PROSTATE CANCER —RESULTS FROM THE SEARCH DATABASE (2015) (0)
MP34-13 COMBINATION THERAPY WITH RADIUM-223 AND ABIRATERONE OR ENZALUTAMIDE IN A LARGE REAL WORLD COHORT (2019) (0)
VALIDATION OF STEPHENSON NOMOGRAM TO PREDICT PSA PROGRESSION FOLLOWING SALVAGE RADIOTHERAPY AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2009) (0)
PD54-05 HALSTEADIAN VIEW OF PROSTATE CANCER: DOES REMOVING MORE NODES AT RADICAL PROSTATECTOMY AFFECT BIOCHEMICAL RECURRENCE? (2022) (0)
360 SHOULD CLINICAL STAGE T2C PROSTATE CANCER BE CLASSIFIED AS INTERMEDIATE- OR HIGH-RISK? - RESULTS FROM THE SEARCH DATABASE (2012) (0)
Does salvage radiation therapy (SRT) change the biology of recurrent prostate cancer (PCa) based on PSA doubling times (PSADT)? Results from the SEARCH database. (2012) (0)
Short title: Low Fat/Fish oil Diet, Serum Eicosanoids and Prostate Cancer (2013) (0)
Phase II prospective randomized trial of weight loss prior to radical prostatectomy (2017) (0)
MP87-03 EVALUATION OF THE ERα AGONIST, GTX-758 (250 MG DAILY), IN MEN WITH METASTATIC (MCRPC) AND NON-METASTATIC CASTRATION RESISTANT PROSTATE CANCER (NMCRPC) (2015) (0)
Mp79-15 Radical Prostatectomy and the Effect of Close Surgical Margins: Analysis From the Search Database (2013) (0)
Is biopsy Gleason sum an independent predictor of biochemical progression following radical prostatectomy after adjusting for the pathological Gleason sum? (2006) (0)
MP22-06 SALVAGE RADIATION THERAPY FOR RECURRENT PROSTATE CANCER: CAN THE PROGNOSTIC GRADE GROUP SYSTEM INFORM TREATMENT TIMING? (2018) (0)
Corrigendum re: "Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT)" [Eur Urol 2020;77:713-24]. (2021) (0)
SMALL TRUS VOLUME PREDICTS CLINICALLY SIGNIFICANT GLEASON SCORE UPGRADING AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2008) (0)
T1C DISEASE IN BLACK MEN: A MORE AGGRESSIVE DISEASE? RESULTS FROM THE SEARCH DATABASE (2008) (0)
NATURAL HISTORY OF SALVAGE RADIOTHERAPY FOR RECURRENT PROSTATE CANCER: RESULTS FROM THE SEARCH DATABASE (2009) (0)
Preclinical Development Effect of a Low-Fat Diet Combined with IGF-1 Receptor Blockade on 22 Rv 1 Prostate Cancer Xenografts (2012) (0)
DOES PRACTICE REFLECT THE EVIDENCE? LYMPH NODE DISSECTION WITH RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2008) (0)
Is There a Role for Medications to Reduce the Need for Prostate Biopsy (2013) (0)
Validity of the National Death Index to ascertain the date and cause of death in men having undergone prostatectomy for prostate cancer (2019) (0)
TITLE : Effect of a low-fat diet combined with IGF-1 receptor blockade on 22 Rv 1 prostate cancer xenografts (2012) (0)
PD31-07 AGENT ORANGE AND LONG-TERM OUTCOMES AFTER RADICAL PROSTATECTOMY (2014) (0)
316 DECREASED MITOCHONDRIAL AND INSULIN PATHWAY GENE EXPRESSION SIGNAL IN PROSTATE CANCER XENOGRAFT MOUSE MODEL WITH VARYING DIETARY FAT SOURCES (2013) (0)
366 BIOPSY-DETECTED GLEASON PATTERN 5 PREDICTS RECURRENCE IN MEN WITH HIGH-RISK PROSTATE CANCER (2013) (0)
479 IS INFILTRATION OF TUMOR-ASSOCIATED MACROPHAGES PREDICTIVE OF BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY? (2012) (0)
237: Gene Expression Profiling of Prostate Cancers from Obese Men Identified HMGCS2 as a Novel Biomarker of Aggressive Prostate Cancer and as a Potential Therapeutic Target (2006) (0)
219 DIFFERENTIAL EFFECT OF CALORIC AND CARBOHYDRATE RESTRICTION ON PROSTATE TUMOR CANCER GROWTH AND GENE EXPRESSION IN A XENOGRAFT MODEL (2012) (0)
Reply to the letter by Demark-Wahnefried et al. (2018) (0)
Lifestyle, IGF-I and prostate cancer (2006) (0)
1038: Percent of Prostate Needle Biopsy Cores with Cancer from the Most Involved Side of the Biopsy is a Better Predictor of PSA Recurrence Following Radical Prostatectomy than the Total Percent of Cores with Cancer (2004) (0)
OUTCOME AMONG MEN WITH PATHOLOGICAL GLEASON SUM 8-10 PROSTATE CANCER AT THE TIME OF RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2008) (0)
Prostate Cancer Prostate-Specific Antigen following Surgery or Radiation for Phase II Study of Pomegranate Juice for Men with Rising Updated (2006) (0)
1638 UNILATERAL PROSTATE CANCER ANALYIS OF PREDICTORS IN SEARCH AND DUKE PROSTATE CENTER DATABASES (2012) (0)
PD32-10 POSITIVE SURGICAL MARGINS IN RADICAL PROSTATECTOMY PATIENTS DO NOT PREDICT LONG-TERM ONCOLOGICAL OUTCOMES: RESULTS FROM SEARCH (2015) (0)
MP37-08 THE ASSOCIATION BETWEEN DIABETES AND PROSTATE CANCER-SPECIFIC MORTALITY IS DIFFERENT IN OBESE AND NON-OBESE MEN AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2020) (0)
Comparison of Low-Carbohydrate Vs . A Low-Fat Diet on Prostate Cancer Biomarkers (2014) (0)
S&T-12 RACE DOES NOT PREDICT THE DEVELOPMENT OF METASTASES IN MEN WITH NON-METASTATIC CASTRATE RESISTANT PROSTATE CANCER (2016) (0)
DOES PSADT AFTER RADICAL PROSTATECTOMY PREDICT OVERALL SURVIVAL?—A REPORT FROM THE SEARCH DATABASE GROUP (2009) (0)
679 LOW SERUM FOLATE IS A RISK FACTOR FOR BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY RESULTS FROM THE SEARCH DATABASE (2012) (0)
MP32-05 CONTEMPORARY HISTORY OF PROGRESSION FOLLOWING ANDROGEN DEPRIVATION THERAPY FOR BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY (2021) (0)
697: Prostate Size is Inversely Associated with Risk of High-Grade, Advanced Prostate Cancer, and Biochemical Progression Following Radical Prostatectomy (2005) (0)
Upgrading and Downgrading of Prostate Needle Biopsies: Risk Factors and Clinical Implications (2011) (0)
1417: Growth Inhiditory Effects of a Low-Fat Diet on Prostate Cancer Cells in Vitro: Results of a Prospective Randomized Dietary Intervention Trial in Men with Prostate Cancer (2005) (0)
Efficacy and safety of darolutamide in Black/African-American patients from the phase III ARAMIS study. (2023) (0)
PD13-10 DIABETES AND PROSTATE CANCER OUTCOMES IN MEN WITH NONMETASTATIC CASTRATE-RESISTANT PROSTATE CANCER: RESULTS FROM THE SEARCH COHORT (2022) (0)
Abstract CN06-03: Green tea and pomegranate: The role of metabolites in chemoprevention (2010) (0)
MP26-19 FURTHER DEFINING THE NATURAL HISTORY OF BIOCHEMICAL PROGRESSION FOLLOWING RADICAL PROSTATECTOMY: DOES PSA DOUBLING TIME CHANGE WITH TIME? (2021) (0)
457: Agent Orange Exposure among Black Men is a Stronger Predictor of PSA Recurrence and Rapid Post-Recurrence Psadt than among White Men (2007) (0)
Title Is clinical stage T 2 c prostate cancer an intermediate-or high-risk disease ? (2015) (0)
HIGHER CHOLESTEROL INCREASES THE RISK OF BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE GROUP (2008) (0)
MP14-12 OBESE CASTRATION-RESISTANT PROSTATE CANCER PATIENTS MAY BE AT A LOWER RISK OF METASTASIS AND ALL-CAUSE MORTALITY: RESULTS FROM THE SEARCH DATABASE (2015) (0)
Global Igfbp 1 deletion does not af fect prostate cancer development in a c-Myc transgenic mouse model (2011) (0)
PD10-06 THE IMPACT OF PRIOR LOCAL THERAPY ON OVERALL SURVIVAL IN MEN WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: RESULTS FROM SEARCH (2018) (0)
MP34-10 PREDICTORS OF SKELETAL RELATED EVENTS AND OVERALL MORTALITY IN MEN WITH METASTATIC, CASTRATION-RESISTANT PROSTATE CANCER: RESULTS FROM THE SEARCH DATABASE (2019) (0)
DO SICKER PEOPLE HAVE WORSE PROSTATE CANCER‐SPECIFIC OUTCOMES AFTER RADICAL PROSTATECTOMY? RESULTS FROM SEARCH: PD40‐12 (2017) (0)
TIMING OF PSA NADIR AFTER RADICAL PROSTATECTOMY AND RISK OF BIOCHEMICAL RECURRENCE: DOES IT MATTER? RESULTS FROM THE SEARCH DATABASE: MP47‐09 (2017) (0)
LYCOPENE AND CHEMOPREVENTION OF PROSTATE CANCER IN THE TRAMP MODEL (2009) (0)
Monocyte counts and prostate cancer outcomes in white and black men: results from the SEARCH database (2021) (0)
Original Article Association between tumor-associated macrophage infiltration, high grade prostate cancer, and biochemical recurrence after radical prostatectomy (2013) (0)
MP67-09 RELATIONSHIP BETWEEN SKIN CANCER AND AGGRESSIVE PROSTATE CANCER: RESULTS FROM THE SEARCH DATABASE (2023) (0)
Title Racial Differences in the Association Between Preoperative Serum Cholesterol and Prostate Cancer Recurrence : Results from the SEARCH Database (2016) (0)
The impact of blue light cystoscopy use among patients with non-muscle invasive bladder cancer in an equal access setting. (2023) (0)
A phase II open-label trial of GTx-758 in men with castration-resistant prostate cancer: Final analysis of the primary endpoint. (2016) (0)
MP32-12 HOW SURGEONS EARN THEIR KEEP: DATA FROM THE CMS DATA RELEASE (2015) (0)
Is clinical stage T2c prostate cancer intermediate- or high-risk disease? Results from the SEARCH database. (2012) (0)
Prostate Cancer: Localized VIIModerated Poster1465 DOES SALVAGE RADIATION THERAPY CHANGE THE BIOLOGY OF RECURRENT PROSTATE CANCER BASED ON PSA DOUBLING TIMES? RESULTS FROM THE SEARCH DATABASE (2012) (0)
VALIDATION OF THE 2015 PROSTATE CANCER PROGNOSTIC GRADE GROUPS FOR PREDICTING LONG‐TERM ONCOLOGIC OUTCOMES IN A SHARED EQUAL ACCESS HEALTH SYSTEM.: PD03‐10 (2017) (0)
Abstract PR-07: Efficacy and safety of darolutamide in Black/African American patients from the phase III ARAMIS trial (2022) (0)
313 LOW FAT FISH OIL (LFFO) DIET DECREASES PRO-INFLAMMATORY EICOSANOIDS AND PROSTATE CANCER CELL CYCLE PROGRESSION (CCP) SCORE IN MEN UNDERGOING RADICAL PROSTATECTOMY (2013) (0)
A modeling study to estimate prostate cancer-specific mortality on active surveillance for men with favorable intermediate-risk prostate cancer: Results from the SEARCH cohort. (2023) (0)
Is body composition linked to prostate cancer survival? (2021) (0)
459: Obesity, Risk of Biochemical Recurrence, and PSADT after Radical Prostatectomy (2007) (0)
Does larger tumor volume explain the higher prostate specific antigen levels in black men with prostate cancer--Results from the SEARCH database. (2015) (0)
MP32-18 METABOLIC SYNDROME AND LONG-TERM PROSTATE CANCER OUTCOMES AFTER RADICAL PROSTATECTOMY (2021) (0)
IBJU | HigH serum folate is associated witH reduced biocHemical recurrence after radical prostatectomy : results from tHe searcH database 513 INtRODUctION Folate is a water-soluble (2013) (0)
Neutrophil, lymphocyte and platelet counts, and risk of prostate cancer outcomes in white and black men: results from the SEARCH database (2018) (0)
DO H2 BLOCKERS LOWER SERUM PSA RESULTS? - DATA FROM THE SEARCH DATABASE (2009) (0)
661 RACE AND LONG-TERM OUTCOMES AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2010) (0)
NATURAL HISTORY OF PERSISTENTLY ELEVATED PSA AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2009) (0)
Title Trends in Radiation-Induced Second Malignancy With Increased Utilization of Intensity Modulated Radiation Therapy for Localized Prostate Cancer (2016) (0)
MP87-07 STATIN USE IS ASSOCIATED WITH IMPROVED PROSTATE CANCER-SPECIFIC OUTCOMES IN WHITE BUT NOT BLACK MEN INITIATING ANDROGEN DEPRIVATION THERAPY (2018) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With William J. Aronson?

William J. Aronson is affiliated with the following schools:

University of California, Los Angeles
Stanford University
Duke University

William J. Aronson's Academic­Influence.com Rankings

William J. Aronson's Degrees

Why Is William J. Aronson Influential?

William J. Aronson's Published Works

Published Works

What Schools Are Affiliated With William J. Aronson?

William J. Aronson's AcademicInfluence.com Rankings